| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 47,283 | 44,156 | 43,612 | 44,637 | | Cost of Revenue | 22,452 | 21,256 | 21,307 | 21,422 | | | Gross Profit | 24,831 | 22,900 | 22,305 | 23,215 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,290 | 4,860 | 4,556 | 5,820 | | Non Recurring |
-
|
-
|
-
| 144,000 | | Others | 3,737 | 3,398 | 3,478 | 3,593 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,804 | 14,642 | 14,271 | (130,198) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13 | 32 | 50 | 135 | | Earnings Before Interest And Taxes | 13,817 | 14,674 | 14,321 | (130,063) | | Interest Expense | 299 | 298 | 290 | 486 | | Income Before Tax | 13,518 | 14,376 | 14,031 | (130,549) | | Income Tax Expense | 1,348 | 306 | 313 | (13,246) | | Minority Interest | (41,541) |
-
|
-
| (13,879) | | | | Net Income From Continuing Ops | (29,371) | 14,070 | 13,718 | (131,182) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (29,371) | 14,070 | 13,718 | (131,182) | | Preferred Stock And Other Adjustments | 27,069 | (13,741) | (13,328) |
-
| | | Net Income Applicable To Common Shares | ($2,302) | $329 | $390 | ($131,182) |
|
0.31% Nasdaq 
0.05%
Income Statement
